Skip to main content

Table 2 Description of clinical research projects in Finland in 2002 and 2007, proportions (%) of projects 1

From: Clinical research in Finland in 2002 and 2007: quantity and type

 

2002

2007

Total

P value6

(n)

794

762

1556

Type

Domestic drug research

11.1

13.6

12.4

0.601

International drug research

18.1

20.4

19.2

0.615

Other medical research

70.8

66.0

68.4

0.090

Main content

Treatment

54.0

56.6

55.3

0.443

Diagnostics and disease

24.0

18.0

21.1

0.192

Biomedical

8.7

5.6

7.2

0.545

Prevention

7.2

5.0

6.1

0.665

Other + missing

6.1

14.8

10.3

--

Approach

Randomized controlled trial

15.9

23.8

19.8

0.092

Trial + intervention

24.3

21.1

22.7

0.475

Observational

43.7

41.5

42.6

0.567

Documents + registers

4.8

6.2

5.5

0.780

Other + missing

11.3

7.4

9.4

--

Main funder 2

Industry

28.7

33.7

31.2

0.236

Public fund

16.3

16.0

16.1

0.966

Health care

52.1

42.3

47.3

0.010

Missing

2.9

8.0

5.4

--

Data collection site 3

University hospital

63.8

43.7

54.0

<0.001

Other public health care facility

13.5

20.1

16.7

0.165

Private care

7.5

7.4

7.4

0.984

Other place

10.9

14.7

12.8

0.417

Missing

4.3

14.1

9.1

--

Total

100

100

100

 

Non-commercial 4

75.4

70.9

73.2

0.087

Multi-center study 5

National

27.8

30.7

29.2

0.497

International

21.3

23.8

22.5

0.576

  1. 1For the explanations of the categories, see Appendix 1.
  2. 2As given in the application. Health care includes state subsidy to hospitals to do research, work done within normal working hours or on own time.
  3. 3In multi-center studies, the place of the principal investigator was chosen for the main research site.
  4. 4Administratively non-commercial i.e. exempted from REC fee.
  5. 5A project can be both national and international multicenter project.
  6. 6Comparison of the two years (t-test); in calculation P values, projects with missing information were ignored.